Eli Lilly's Retatrutide, a new GLP-1 drug, achieved an unprecedented 28.7% average body weight loss in trials, outperforming Zepbound. It also significantly reduced knee pain. Some side effects and dropouts were noted.
Research explores lipoedema, a painful condition causing fat build-up. Low-carb diets show promise for pain relief and weight loss. Compression garments provide relief. More research is needed for effective treatment.
Study reveals tirzepatide combined with menopause hormone therapy boosts weight loss in postmenopausal women versus tirzepatide alone, potentially offering a more effective weight management solution.
